REGN

Regeneron Pharmaceuticals, Inc. (REGN) Investor Questions

Regeneron Pharmaceuticals, Inc. (REGN) investor questions: stock forecasts, price data, dividends, earnings dates, valuation and risk, with missing data clearly identified.

Research record updated: . Individual measures may refer to different reporting periods.

Company
Regeneron Pharmaceuticals, Inc.
Sector
Healthcare
Industry
Biotechnology
Overall BTI score
68
Annual revenue
$14.34B
Annual net income
$4.50B
Annual free cash flow
$4.08B

Regeneron Pharmaceuticals, Inc. (REGN) Investor Questions research

Regeneron Pharmaceuticals, Inc. trades under the ticker REGN. The company is classified in the Healthcare sector and the Biotechnology industry.

Investors commonly review REGN through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.

What is Regeneron Pharmaceuticals, Inc. (REGN) stock?

Regeneron Pharmaceuticals, Inc. trades under ticker REGN. Its recorded sector is Healthcare. Its industry is Biotechnology.

What does the REGN stock forecast mean?

BTI's forecast summarizes available short-term and long-term research scores for REGN. These scores are not price targets, analyst consensus or probabilities of a positive return. Compare the Forecast, Earnings and Valuation pages before interpreting the outlook.

Where can I find the REGN stock price today?

Check the REGN quote and chart in the research workspace, including currency, trading session and quote timestamp. The research-record update time on this page is not a live quote timestamp.

Does REGN pay dividends?

Dividend yield is not supplied in this REGN research record. Missing data does not establish that Regeneron Pharmaceuticals, Inc. does not pay dividends. Check the company's dividend announcements for declared amounts and dates.

When does REGN report earnings?

The available earnings record lists 2026-07-30 for REGN. This stored date may be historical; it is not confirmation of the next announcement. Check Regeneron Pharmaceuticals, Inc.'s investor-relations calendar for the current schedule; estimated dates can change.

How can I assess REGN's valuation and risk?

Compare Regeneron Pharmaceuticals, Inc.'s financial results, cash flow, debt and valuation assumptions with its operating risks and competitors. The Financials, Valuation and Statistics pages provide the available figures. A BTI score is a research input, not a personalized recommendation.